Latest Neurobiological brain disorder Stories
A widely prescribed MS treatment may not be as effective in the long term as some would have hoped. New research shows that there’s no strong evidence that a group of drugs, beta interferons (ß-IFNs), prescribed to treat MS, had a measurable impact on the long-term disability progression of the disease.
The impact of traumatic injuries to the brain – whether sustained in combat or on the playing fields of America's schools – is a major topic for international migraine specialists the week of June 18 as they gather in Los Angeles for the 54th Annual Scientific Sessions of the American Headache Society.
The first study to examine the actual willingness of older adults to be screened for dementia has found that acceptance of screening is pervasive, although it varies by age.
A new study shows that a practical clinical tool developed by researchers from the Regenstrief Institute and the Indiana University School of Medicine to measure severity of dementia symptoms is reliable and valid.